2289 On Other Exchanges
Symbol
Exchange
Hong Kong

charmacy pharmaceutical co-h (2289) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CHARMACY PHARMACEUTICAL CO-H (2289)
\

Related News

No related news articles were found.

charmacy pharmaceutical co-h (2289) Related Businessweek News

No Related Businessweek News Found

charmacy pharmaceutical co-h (2289) Details

Charmacy Pharmaceutical Co., Ltd. distributes pharmaceutical products in the People's Republic of China. The company offers western medicines, Chinese patent medicines, and healthcare products to downstream distributors, as well as retail terminals, including pharmacies, clinics, and private hospitals. It also provides consultation service on pharmaceutical products; and operates Charmacy e-Medicine, a B2B e-commerce platform to place procurement orders online. The company was formerly known as Chuangmei Pharmaceutical Co., Ltd. and changed its name to Charmacy Pharmaceutical Co., Ltd. in July 2016. Charmacy Pharmaceutical Co., Ltd. was founded in 1984 and is headquartered in Shantou, the People's Republic of China.

794 Employees
Last Reported Date: 04/18/19
Founded in 1984

charmacy pharmaceutical co-h (2289) Top Compensated Officers

Chairman & CEO
Total Annual Compensation: CNY714.9K
CFO, Company Secretary & Executive Director
Total Annual Compensation: CNY535.7K
Chief Marketing Officer, VP & Executive Direc...
Total Annual Compensation: CNY537.2K
Compensation as of Fiscal Year 2018.
charmacy pharmaceutical co-h
Charmacy Pharmaceutical Co., Ltd. Approves Final Dividend for the Year Ended 31 December 2018

Charmacy Pharmaceutical Co., Ltd. approved final dividend of RMB 0.30 (tax inclusive) per share for the year ended 31 December 2018 to the Shareholders whose names appear on the register of members of the Company on 12 June 2019.

Charmacy Pharmaceutical Co., Ltd. Announces Audited Consolidated and Parent Earnings Results for the Year Ended December 31, 2018

Charmacy Pharmaceutical Co., Ltd. announced audited consolidated and parent earnings results for the year ended December 31, 2018. For the year, the company's total operating revenue was RMB 3,935,245,977.18 compared to RMB 4,095,835,450.18 a year ago. Operating profit was RMB 60,304,013.91 compared to RMB 55,924,854.49 a year ago. Total profit was RMB 63,655,425.85 compared to RMB 59,857,314.29 a year ago. Net profit was RMB 44,761,992.94 compared to RMB 44,294,872.70 a year ago. Basic earnings per share was RMB 0.4207 per share compared to RMB 0.4144 per share a year ago. For the year, on parent basis, Operating revenue was RMB 1,603,236,297.38 against RMB 1,644,119,714.18 a year ago. Operating profit was RMB 38,214,783.30 against RMB 45,982,123.51 a year ago. Net profit was RMB 35,496,243.55 against RMB 44,710,564.65 a year ago.

Charmacy Pharmaceutical Co., Ltd. Announces Audited Consolidated Earnings Results for the Year Ended December 31, 2018

Charmacy Pharmaceutical Co., Ltd. announced audited consolidated earnings results for the year ended December 31, 2018. For the year, the company's total operating revenue was RMB 3,935,245,977.18 compared to RMB 4,095,835,450.18 a year ago. Operating profit was RMB 60,304,013.91 compared to RMB 55,924,854.49 a year ago. Total profit was RMB 63,655,425.85 compared to RMB 59,857,314.29 a year ago. Net profit was RMB 44,761,992.94 compared to RMB 44,294,872.70 a year ago. Basic and diluted earnings per share was RMB 0.4207 per share compared to RMB 0.4144 per share a year ago.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

2289 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 2289.
View Industry Companies
 

Industry Analysis

2289

Industry Average

Valuation 2289 Industry Range
Price/Earnings 15.2x
Price/Sales 0.2x
Price/Book 1.5x
Price/Cash Flow 15.2x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact CHARMACY PHARMACEUTICAL CO-H, please visit www.chmyy.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.